Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1088 of 5804
-
Could donor milk save tiny babies from deadly gut disease?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether supplementing with pasteurized donor human milk (pHDM) or preterm formula (PTF) when own mother's milk (OMM) is insufficient can improve outcomes in very preterm infants born before 29 weeks of gestation. It also aims to asse…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug aims to boost brain energy in Parkinson's patients
Disease control Recruiting nowThe main goal of the study is to investigate how well the new drug SUL-238 works in Parkinson's Disease (PD). This is done by means of an MRS scan. An MRS scan is similar to a regular MRI scan. It will also learn about the safety of new drug SUL-238. The main questions it aims to…
Phase: PHASE2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control ENROLLING_BY_INVITATIONThis multi-center, observational, post-intervention LTFU study will monitor for safety and efficacy of AAVAnc80- antiVEGF in individuals with vestibular schwannoma who have previously received an intracochlear administration of AAVAnc80-antiVEGF in an interventional clinical tria…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a cheap vitamin pill boost brain healing after head injury?
Disease control Recruiting nowThis study is a Phase II, randomized, quadruple-blinded, placebo-controlled clinical trial designed to test whether vitamin D₃ supplementation can improve recovery after mild-to-moderate traumatic brain injury (TBI) in adults. Traumatic brain injury often leads to inflammation a…
Phase: PHASE2 • Sponsor: Lagos State University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New clip device aims to fix leaky heart valve without open surgery
Disease control Recruiting nowThe goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Immune cells engineered to fight mesothelioma enter human testing
Disease control Recruiting nowThis example study evaluates locoregional allogeneic dual-target mesothelin/FAP CAR-NK cells in adults with unresectable, recurrent, or refractory pleural or peritoneal mesothelioma. Eligible participants must have central confirmation of MSLN-positive tumor cells and FAP-positi…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to cut opioid prescriptions after prostate surgery
Symptom relief Recruiting nowThis prospective, interventional, open-label, phase 3 randomized study evaluates a multimodal analgesia discharge pathway to reduce automatic opioid prescribing following routine robotic-assisted laparoscopic prostatectomy (RALP). Patients are counseled on post-operative pain man…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Pharmacists to the rescue: new study aims to protect kidneys in diabetes patients without a family doctor
Disease control Recruiting nowType 2 diabetes is the leading cause of chronic kidney disease, which can result in serious complications such as kidney failure and heart disease. Although effective medications exist to slow the progression of kidney damage, they are often underused in primary care, particularl…
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
More chemo before surgery: better odds for rare thymic cancer?
Disease control Not yet recruitingThis randomized controlled trial compares 6 versus 3 cycles of neoadjuvant chemotherapy in patients with potentially resectable locally advanced thymic epithelial tumors (TETs, WHO type AB/B/C, AJCC TNM stage IIIA-IVA). Patients are randomized 1:1 to receive either 6 or 3 cycles …
Phase: PHASE2, PHASE3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New blood test could replace risky prenatal procedures
Diagnosis Not yet recruitingSince the discovery of a small fraction of circulating cell-free fetal DNA (ccffDNA) in the blood of the mother, non-invasive prenatal diagnosis (NIPD) techniques using a simple blood sample have been developed to 1) screen for chromosomal abnormalities, 2) diagnose fetal sex, an…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Virtual reality meets AI: a new hope for stroke arm recovery?
Symptom relief Not yet recruitingBackground: Upper limb motor deficits are common after stroke, and early rehabilitation is crucial for functional recovery. Virtual reality (VR) combined with artificial intelligence (AI) has shown potential to enhance motor learning, but evidence from randomized controlled trial…
Phase: NA • Sponsor: Complejo Asistencial Universitario de León Urgencias • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New eye drug could mean fewer shots for PCV patients
Disease control Recruiting nowTo evaluate the Efficacy of a personalized treat-and-extend regimen of faricimab for treatment-naive polypoidal choroidal vasculopathy
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug NTB003 aims to reduce bulging eyes in thyroid disease
Disease control Not yet recruitingMulticentre, Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of NTB003 in Participants with Thyroid Eye Disease
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a calming drug tame the deadly stress of sepsis?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether early administration of dexmedetomidine can improve autonomic nervous system regulation and clinical outcomes in adult patients with septic shock. It will also evaluate the safety of dexmedetomidine in this population. The main…
Phase: PHASE4 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a prostate cancer imaging tool help fight brain tumors?
Knowledge-focused Not yet recruitingMeningioma is the most common intracerebral tumor in adults. Conventional treatment includes surgery and external beam radiation therapy. However, when multiple surgeries and radiation therapy sessions fail to control tumor progression, no standard treatment is adopted. Therefore…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Could a simple steroid course save lives in severe respiratory infections?
Disease control Not yet recruitingMulticenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection a…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New injection plus radiation shows promise against cervical cancer
Disease control Recruiting nowThis is a seamless Phase 1/2 study consisting of two components. Phase 1 component is a dose-escalation, single arm, open label study in 10 patients to evaluate the safety and tolerability of KRC 01. Phase 2 component is a randomized, open label, controlled, multi-center study in…
Phase: PHASE1 • Sponsor: Kortuc, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate if CALM-TF (Trauma-Focused Managing Cancer and Living Meaningfully) is effective in treating traumatic stress symptoms in women with advanced ovarian cancer. It will also learn whether the efficacy differs at new diagnosis versus …
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Shorter blood thinner course after stents may cut bleeding risk
Disease control Not yet recruitingPatients with acute coronary syndrome (ACS) who have both high ischemic risk and high bleeding risk represent a challenging population following percutaneous coronary intervention (PCI), as prolonged dual antiplatelet therapy (DAPT) may reduce ischemic events but increases bleedi…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI-Powered diet coach aims to revolutionize diabetes care in china
Disease control Not yet recruitingThe goal of this cluster randomized clinical trial is to learn if an AI-enabled blended care model (the BRIDGE program) works to treat type 2 diabetes in adults. It will also learn about the cost-effectiveness and implementation feasibility of this model in primary care settings.…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC